Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000551537 | SCV000636288 | likely benign | X-linked Emery-Dreifuss muscular dystrophy | 2023-12-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618581 | SCV000735532 | uncertain significance | Cardiovascular phenotype | 2019-05-29 | criteria provided, single submitter | clinical testing | The p.R204H variant (also known as c.611G>A), located in coding exon 6 of the EMD gene, results from a G to A substitution at nucleotide position 611. The arginine at codon 204 is replaced by histidine, an amino acid with highly similar properties. This variant has been detected in conjunction with other genetic alterations by exome sequencing in a family with Ohdo syndrome, the Maat-Kievit-Brunner (MKB) type (Vulto-van Silfhout AT et al. Am J Hum Genet. 2013;92:401-6). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Ce |
RCV000762691 | SCV000893027 | uncertain significance | not provided | 2018-04-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001829576 | SCV002084706 | uncertain significance | Emery-Dreifuss muscular dystrophy | 2021-04-07 | no assertion criteria provided | clinical testing |